Agios Pharmaceuticals Inc...

NASDAQ: AGIO · Real-Time Price · USD
37.06
-0.39 (-1.04%)
At close: Aug 19, 2025, 12:06 PM

Agios Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
673.73M -352.09M -231.8M -356.51M
Depreciation & Amortization
5.65M 6.62M 8.56M 9.24M
Stock-Based Compensation
42.85M 44.77M 49.3M 53.51M
Other Working Capital
-16.53M 864K -9.17M -38.69M
Other Non-Cash Items
-1.09B 23.69M -119.1M 9.54M
Deferred Income Tax
n/a n/a n/a -86.27M
Change in Working Capital
-19.77M -19.06M -16.43M -36.82M
Operating Cash Flow
-389.84M -296.06M -309.48M -407.32M
Capital Expenditures
-1.69M -999K -4.88M -5.74M
Cash Acquisitions
40K n/a 132.75M n/a
Purchase of Investments
-1.54B -417.93M -1.03B -1.38B
Sales Maturities Of Investments
818.38M 674.68M 1.15B 829.8M
Other Investing Acitivies
1.09B -16.18M n/a 1.8B
Investing Cash Flow
363.44M 239.57M 243.26M 1.25B
Debt Repayment
n/a n/a -331K -578K
Common Stock Repurchased
n/a n/a n/a -802.49M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
14.44M 5.43M 2.68M 37.3M
Financial Cash Flow
14.44M 5.43M 2.35M -765.77M
Net Cash Flow
-11.96M -51.05M -63.87M 75.69M
Free Cash Flow
-391.53M -297.06M -314.36M -413.06M